SCHEMBL1190087

SCHEMBL1190087

CC1(O)CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2019766 1.00
SCHEMBL2012682 1.00
Hydrochloric Acid SCHEMBL22977509 0.97
Hydrochloric Acid SCHEMBL21200455 0.97
Hydrochloric Acid SCHEMBL1935405 0.97
SCHEMBL1428054 0.83
SCHEMBL1428041 0.83
SCHEMBL1427324 0.83
SCHEMBL14801159 0.81
SCHEMBL86857 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 640 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260000692-A1 Substituted N-(Pyridin-2-yl)Acetamide Derivatives as CDK12/13 Inhibitors AURIGENE ONCOLOGY LIMITED (IN) 2026-01-01 US claimed
CN-120025352-A Condensed heterocyclic compound, pharmaceutical composition and application thereof 北京康辰药业股份有限公司 2025-05-23 CN claimed
US-20240308980-A1 HETEROARYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2024-09-19 US claimed
CN-118619923-A Preparation method and application of tetrahydroisoquinoline PD-L1 inhibitor 大连理工大学 2024-09-10 CN claimed
CN-114746411-B Substituted tricyclic compounds 印度鲁宾有限公司 2024-06-25 CN claimed
CN-114507227-B Benzisothiazole compound, preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2024-06-21 CN claimed
CN-114591318-B Pyrazolo heterocyclic compound, preparation method thereof, pharmaceutical composition and application 中国医学科学院药物研究所 2024-06-21 CN claimed
EP-4065575-B1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LTD (IN) 2024-01-31 EP claimed
CN-116348458-A Imidazolylpyrimidinylamine compounds as CDK2 inhibitors 因赛特公司 2023-06-27 CN claimed
US-20230024173-A1 IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS INCYTE CORPORATION 2023-01-26 US claimed
CN-114746411-A Substituted tricyclic compounds 印度鲁宾有限公司 2022-07-12 CN claimed
CN-114591318-A Pyrazolo heterocyclic compound, preparation method thereof, pharmaceutical composition and application 中国医学科学院药物研究所 2022-06-07 CN claimed
WO-2022105782-A1 BENZISOTHIAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 中国医学科学院药物研究所 2022-05-27 WO claimed
CN-114507227-A Benzisothiazole compound, preparation method thereof, pharmaceutical composition and application 中国医学科学院药物研究所 2022-05-17 CN claimed
CN-107207482-A Pyrimidine derivatives for treating cancer 默克专利股份公司 2017-09-26 CN claimed
CN-105102449-B Antiviral compound 豪夫迈·罗氏有限公司 2017-06-13 CN claimed
WO-2016112088-A1 ARYLOXYACETYLINDOLES AND ANALOGS AS ANTIBIOTIC TOLERANCE INHIBITORS SPERO THERAPEUTICS, INC. (US) 2016-07-14 WO claimed
EP-2964635-A1 ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2016-01-13 EP claimed
WO-2014135495-A1 ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2014-09-12 WO claimed
EP-0326916-A2 Quinolone- and naphthyridone-carboxylic acid derivatives, method for their preparation and antibacterial agents and food additives containing them BAYER AG (DE) 1989-08-09 EP claimed